image
Healthcare - Biotechnology - NASDAQ - US
$ 40.76
-11 %
$ 3.21 B
Market Cap
-7.65
P/E
BALANCE SHEET
1.71 B ASSETS
-10.06%
2.8 B LIABILITIES
3.27%
-1.1 B EQUITY
-34.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet PTC Therapeutics, Inc.
image
Current Assets 1.37 B
Cash & Short-Term Investments 1.14 B
Receivables 159 M
Other Current Assets 67.3 M
Non-Current Assets 339 M
Long-Term Investments 0
PP&E 118 M
Other Non-Current Assets 222 M
66.84 %9.30 %3.95 %6.90 %13.01 %Total Assets$1.7b
Current Liabilities 581 M
Accounts Payable 17.3 M
Short-Term Debt 26.7 M
Other Current Liabilities 537 M
Non-Current Liabilities 2.22 B
Long-Term Debt 285 M
Other Non-Current Liabilities 1.94 B
19.16 %10.18 %69.09 %Total Liabilities$2.8b

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 779.7 594.0 410.7 773.4 208.8 686.6 227.6 191.2 231.7 338.9 315.2 15.4 2.7 28.4
Short Term Investments 360.0 282.7 130.9 583.7 894.8 398.5 58.1 79.5 173.3 280.9 265.5 127.1 0 0
Receivables 158.6 161.0 155.6 110.5 69.9 55.5 67.9 40.4 24.9 11.1 4.4 1.0 1.0 1.2
Inventory 23.2 30.6 21.8 15.9 18.7 19.3 16.1 10.8 0 0 0 0 0 0
Other Current Assets 44.1 150.3 105.7 109.4 78.9 35.8 18.5 13.3 9.4 11.9 7.8 1.6 1.7 3.4
Total Current Assets 1 365.5 1 218.6 693.8 773.4 1 231.7 779.3 320.9 249.1 261.3 355.9 323.6 145.0 4.6 33.1
PP&E 117.7 179.0 175.0 130.0 118.2 21.5 12.7 8.4 7.4 9.0 9.2 6.7 8.3 10.8
Intangible Assets 118.8 379.5 705.9 724.8 715.3 710.5 701.0 133.0 0 0 0 0 0 0
Goodwill 82.3 82.3 82.3 82.3 82.3 82.3 82.3 0 0 0 0 0 0 0
Long Term Investments 0 0 16.1 7.5 7.5 7.5 0 0 0 0 0 0 0 0
Other Long Term Assets 20.7 36.2 48.6 227.5 60.6 30.1 2.3 1.2 0.6 3.1 0.5 0.1 0.2 0.3
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 705.0 1 895.7 1 705.6 1 938.1 2 208.3 1 623.8 1 119.2 391.7 269.3 368.0 333.2 151.9 13.1 44.1
LIABILITIES
Accounts Payable 17.3 6.0 27.3 23.0 18.7 10.3 6.0 15.3 6.3 5.8 4.1 1.1 0.6 1.9
Short Term Debt 26.7 210.3 24.7 170.1 17.5 25.2 11.7 0 0 0 0 48.6 K 4.4 7.1
Other Current Liabilities 526.8 385.9 348.2 314.9 232.7 192.1 145.4 62.8 43.3 39.5 25.0 11.1 23.1 11.2
Total Current Liabilities 581.0 603.1 406.2 509.3 277.3 235.9 166.8 82.0 49.6 45.4 32.5 13.1 28.2 43.1
Long Term Debt 285.4 2 018.8 691.3 375.6 411.7 302.9 141.3 145.0 98.2 91.8 0 0 61 K 4.5
Deferred Tax Income 0 0 102.8 137.1 136.7 130.9 122.0 (3.9) 0 (0.1) 0 0 0.4 214.4
Other Liabilities 1 936.7 92.3 852.4 914.6 900.5 356.4 328.6 0.2 0.3 2.0 2.3 2.2 2.2 4.2
Total Liabilities 2 803.1 2 714.3 2 052.7 1 936.6 1 726.3 1 029.5 768.5 235.2 149.8 69.6 34.8 15.4 32.3 282.8
EQUITY
Common Stock 77 K 75 K 72 K 71 K 70 K 62 K 51 K 42 K 34 K 34 K 33 K 24.3 K 545 133
Retained Earnings (3 646.9) (3 283.6) (2 657.0) (2 098.0) (1 628.9) (1 190.5) (938.9) (814.1) (735.1) (593.0) (422.6) (328.8) (277.2) (250.6)
Other Accumulative Comprehensive Income/Loss (25.9) (1.3) 4.8 (24.3) (61.0) (10.6) 1.5 4.0 (1.5) (1.2) (0.7) 70.4 K (20.3) (17.6)
Total Equity (1 098.1) (818.6) (347.1) 1.4 482.0 594.3 350.7 156.4 119.6 298.5 298.5 136.5 (19.2) (238.6)
Total Liabilities and Equity 1 705.0 1 895.7 1 705.6 1 938.1 2 208.3 1 623.8 1 119.2 391.7 269.3 368.0 333.2 151.9 13.1 44.1
SHARES OUTSTANDING
Common Shares Outstanding 76.8 74.8 71.7 70.5 66.0 58.9 46.6 39.1 34.0 33.6 31.6 12.8 14.2 14.2